Primary study · included by 1 review

A 13-gene signature prognostic of HPV-negative OSCC: discovery and external validation.

Lohavanichbutr 2013 · Lohavanichbutr Pawadee, Méndez Eduardo, Holsinger F Christopher, et al. · Clinical cancer research : an official journal of the American Association for Cancer Research · 2013

Included by

Outcome this study informsPooled effectEvidenceCertainty
Overall survival
High computational stemness signature or risk score (mRNAsi, lncRNA, multigene, CpG signatures) vs Low stemness signature or risk score
HR 2.24 [1.61, 3.12]6 studiesModerate
Overall survival
High computational stemness signature or risk score (mRNAsi, lncRNA, multigene, CpG signatures) vs Low stemness signature or risk score
HR 2.13 [1.56, 2.89]5 studiesGRADE not reported

1 including review in total.